Elevance Health (ELV) Receivables - Other (2009 - 2026)

Elevance Health (ELV) has 18 years of Receivables - Other data on file, last reported at $6.2 billion in Q1 2026.

• Receivables - Other for Q1 2026 came in at $6.2 billion, down 6.22% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.2 billion (down 6.22% YoY), and the FY2025 annual result was $6.3 billion, up 4.84% from the prior year.
• Receivables - Other slipped to $6.2 billion in Q1 2026 per ELV's latest filing, from $6.3 billion in the prior quarter.
• Over five years, Receivables - Other peaked at $7.7 billion in Q3 2025 and troughed at $3.3 billion in Q1 2022.
• A 5-year average of $5.4 billion and a median of $5.4 billion in 2023 frame the typical range for Receivables - Other.
• The sharpest annual moves came in 2022 and 2026: Receivables - Other jumped 186.53% in 2022, then declined 6.22% in 2026.
• A 5-year view of Receivables - Other shows it stood at $4.3 billion in 2022, then advanced by 25.76% to $5.4 billion in 2023, then climbed by 11.3% to $6.0 billion in 2024, then climbed by 4.84% to $6.3 billion in 2025, then declined by 2.22% to $6.2 billion in 2026.
• Business Quant data shows ELV's Receivables - Other at $6.2 billion in Q1 2026, $6.3 billion in Q4 2025, and $7.7 billion in Q3 2025.